Merkel cell carcinoma in a patient with Recklinghausen neurofibromatosis.

Int J Oral Maxillofac Surg

Department of Oral and Maxillofacial Surgery, Theagenion Cancer Hospital, Thessaloniki, Greece.

Published: June 1998

AI Article Synopsis

  • A rare instance of Merkel cell carcinoma developed on the cheek, originating from a cutaneous neurofibroma in a patient with Recklinghausen neurofibromatosis.
  • The case highlights the connection between neurofibromatosis and the risk of developing certain skin cancers.
  • The accompanying literature review provides context and insights into similar cases and the implications for patients with neurofibromatosis.

Article Abstract

A rare case is described of Merkel cell carcinoma of the cheek arising in a cutaneous neurofibroma in a patient with Recklinghausen neurofibromatosis. The relevant literature is reviewed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0901-5027(98)80013-1DOI Listing

Publication Analysis

Top Keywords

merkel cell
8
cell carcinoma
8
patient recklinghausen
8
recklinghausen neurofibromatosis
8
carcinoma patient
4
neurofibromatosis rare
4
rare case
4
case described
4
described merkel
4
carcinoma cheek
4

Similar Publications

In this study, an advanced nanofiber breast cancer model was developed and systematically characterized including physico-chemical, cell-biological and biophysical parameters. Using electrospinning, the architecture of tumor-associated collagen signatures (TACS5 and TACS6) was mimicked. By employing a rotating cylinder or static plate collector set-up, aligned fibers (TACS5-like structures) and randomly orientated fibers (TACS6-like structures) fibers were produced, respectively.

View Article and Find Full Text PDF

Objective: The lack of consensus on the benefits and harms of standard therapies, including surgery (SRx), radiotherapy (RTx), chemotherapy (CTx), and their combinations among early-stage MCC, prompted this study.

Methods: A systematic review and meta-analysis of randomized and non-randomized studies published between January 01, 1972, and January 31, 2023, and having overall survival (OS), local recurrence (LR), regional recurrence (RR), disease-specific survival (DSS), and/or disease-free survival (DFS) as outcomes was conducted using the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed (NCBI), Scopus (ELSEVIER), and Web of Science (CLAVIRATE) databases. Hazard ratios (HRs) and their variances were pooled using the inverse variance heterogeneity model.

View Article and Find Full Text PDF

Capicua transcriptional repressor (CIC)-rearranged sarcoma (CRS) is a rare and recently described tumor that most commonly affects patients between 15 and 30 years of age. It is an undifferentiated round cell malignancy, with a disease defining CIC fusion, with double homeobox 4 (DUX4) being the most common partner. Here, we report a 77-year-old woman who presented with a cutaneous thigh mass with a clinical morphology suggesting Merkel cell carcinoma.

View Article and Find Full Text PDF

"Chasing Rainbows" Beyond Kaposi Sarcoma's Dermoscopy: A Mini-Review.

Dermatopathology (Basel)

November 2024

Second Dermatology Department, School of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

The dermoscopic rainbow pattern (RP), also known as polychromatic pattern, is characterized by a multicolored appearance, resulting from the dispersion of polarized light as it penetrates various tissue components. Its separation into different wavelengths occurs according to the physics principles of scattering, absorption, and interference of light, creating the optical effect of RP. Even though the RP is regarded as a highly specific dermoscopic indicator of Kaposi's sarcoma, in the medical literature, it has also been documented as an atypical dermoscopic finding of other non-Kaposi skin entities.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!